InsidersTradesSigma
申报总数
公司
▲ 买入（0 笔）
▼ 卖出（0 笔）
内部人交易记录
高级管理人员已披露买入
0
已披露卖出
0
尚无足够的、已确定 T+90 期限的买入信号来衡量交易记录。
信号历史
无可用的信号评分。
Browse the detailed record of transactions filed by Pahl, Prof. Dr. Andreas, Management Board. Insider active across 1 company, notably Heidelberg Pharma AG. In total, 2 filings have been published. History available since 23 July 2025. The latest transaction was disclosed on 23 July 2025 (Other). Regulator: BaFin. The full history is openly available.
Companies and markets linked to Pahl, Prof. Dr. Andreas
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
申报2 总计
90,000 股@ €1.8950.0% 占其流量ShareISIN DE000A11QVV0BAFIN:40005738
90,000 股@ €1.8950.0% 占其流量ShareISIN DE000A11QVV0BAFIN:40005738-8c5802509077
2 条申报中的 2 条
About Pahl, Prof. Dr. Andreas
Prof. Dr. Andreas Pahl is a member of the Management Board at Heidelberg Pharma AG. He brings valuable expertise in the field of pharmaceutical research and development. His role involves overseeing strategic operations and guiding the scientific direction of the company.
